Suppr超能文献

通过血清肌酐和β2-微球蛋白预测肾小球滤过率

Prediction of glomerular filtration rate by serum creatinine and beta 2-microglobulin.

作者信息

Shea P H, Maher J F, Horak E

出版信息

Nephron. 1981;29(1-2):30-5. doi: 10.1159/000182234.

Abstract

The reciprocal of serum creatinine concentration (1/Cr) is often used to predict glomerular filtration rate (GFR). Serum creatinine also varies with age, size, and muscle mass, and so it may inaccurately estimate GFR. The reciprocal of serum beta 2-microglobulin (1/beta 2mu) has been proposed as an alternative estimator of GFR. This study compares 1/Cr and 1/beta 2mu as predictors of GFR as measured by 125I-iothalamate clearance (CIOT) and creatinine clearance (CCr) in 29 subjects with a wide range of age, size and kidney function, and including 12 chronic hemodialysis patients. 1/beta 2mu was a better predictor of CIOT (r=0.90) and CCr (r=0.87) than 1/Cr (r=0.50 and 0.78) was. In fact, in the nondialysis population, 1/beta 2mu predicted CIOT (r=0.86) about as well as CCr predicted CIOT (r=0.87). Beta 2mu was less dependent on body size than Cr and unlike Cr, was not influenced by dialysis and did increase as GFR decreased with age. Beta 2mu can be useful as an alternative clinical estimate of GFR, particularly when Cr is considerably influenced by factors other than renal function.

摘要

血清肌酐浓度的倒数(1/Cr)常被用于预测肾小球滤过率(GFR)。血清肌酐也会随年龄、体型和肌肉量而变化,因此它可能会不准确地估算GFR。血清β2-微球蛋白的倒数(1/β2mu)已被提议作为GFR的另一种估算指标。本研究比较了在29名年龄、体型和肾功能范围广泛的受试者(包括12名慢性血液透析患者)中,1/Cr和1/β2mu作为通过125I-碘肽酸盐清除率(CIOT)和肌酐清除率(CCr)测量的GFR预测指标的情况。与1/Cr(r = 0.50和0.78)相比,1/β2mu是CIOT(r = 0.90)和CCr(r = 0.87)更好的预测指标。事实上,在非透析人群中,1/β2mu预测CIOT(r = 0.86)的效果与CCr预测CIOT(r = 0.87)的效果相当。β2mu比Cr对体型的依赖性更小,并且与Cr不同,它不受透析影响,且确实会随着GFR随年龄下降而升高。β2mu可作为GFR的一种替代临床估算指标,尤其是当Cr受到肾功能以外的因素显著影响时。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验